
Glide Pharma makes two senior hires
pharmafile | July 10, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Glide Pharma, Richard Bungay, Tony Mills
Oxford-based development and device firm Glide Pharma has appointed Richard Bungay as its chief financial officer (CFO) and Dr Tony Mills as director of business development.
Bungay (pictured) has over 20 years’ corporate experience of the biotech and pharma sectors. His recent roles include CFO at Verona Pharma and chief executive of Chroma Therapeutics, prior to which he was Chroma’s CFO.
Prior to that he was director of corporate communications and strategic planning at Celltech, following a period as finance director for AstraZeneca’s respiratory and inflammation therapy area. He also held a number of finance positions at Celltech, including financial controller.
Mills takes over 25 years’ commercial experience of the life sciences industry to Glide. He joins the company from the drug delivery firm Q Chip where he was chief commercial officer. He was also VP, business development at BioVex, and held several roles at BTG International including VP, genomics and proteomics.
Dr Mark Carnegie-Brown, Glide Pharma’s chief executive says: “I’m delighted to welcome Richard and Tony to the Glide team. Both are seasoned industry professionals.”






